SCHEMBL8330910

SCHEMBL8330910

CC(C)(C)OC(=O)C(Br)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
CYP1A2 P05177 2/20 0.52
NPSR1 Q6W5P4 3/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 2/20 0.38
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
MAPT P10636 2/20 0.38
HSD17B10 Q99714 1/20 0.38
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
CASR P41180 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3414946 0.85 ALDH1A1 (0.70) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL7877446 0.84 ALDH1A1 (0.56) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL8805565 0.84 ALDH1A1 (0.56) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL16811748 0.84 ALDH1A1 (0.56) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL4558503 0.84 ALDH1A1 (0.72) ALDH1A1CYP1A2NPSR1TSHRTDP1
SCHEMBL8804897 0.80 ALDH1A1 (0.51) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL7874932 0.80 ALDH1A1 (0.51) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL17083920 0.79 ALDH1A1 (0.64) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL8804894 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2NPSR1TSHRHTT
SCHEMBL7091337 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2NPSR1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9625448-B2 Double caged GABA compounds, bis-CNB-GABA THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-04-18 US disclosed
US-20150266809-A1 DOUBLE CAGED GABA COMPOUNDS, BIS-CNB-GABA THE TRUSTEES OF PRINCETON UNIVERSITY 2015-09-24 US disclosed
US-5888829-A Photolabile caged ionophores and method of using in a membrane separation process MOLECULAR PROBES, INC. (US) 1999-03-30 US disclosed
US-5635608-A CONTAINS PHOTOREMOVABLE ALPHA-CARBOXY-SUBSTITUTED ORTHO-NITROBENZYL GROUP THAT CHANGES THE FLUORESCENCE AND BIOLOGICAL PROPERTIES OF THE COMPOUND MOLECULAR PROBES, INC. (US) 1997-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266809-A1 DOUBLE CAGED GABA COMPOUNDS, BIS-CNB-GABA GABRB2, GABRB3, GABRB1 ALDH1A1 2034/4885CYP1A2 1703/4885NPSR1 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.